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The “fetal origins hypothesis” or concept of “developmental programming” suggests that faltering fetal growth and subsequent
catch-up growth are implicated in the aetiology of cardiovascular disease. Associations between reduced birth weight, rapid
postnatal weight gain, and asthma suggest that there are fetal origins to respiratory disease. The present paper ﬁrst summarises the
literature relating birth weight and post natal growth trajectories to asthma outcomes. Second, issues regarding the interpretation
of antenatal fetal ultrasound measurements are discussed. Finally, recent reports linking antenatal measurement and growth
trajectory to early childhood asthma outcomes are discussed. Understanding the nature and timing of factors which inﬂuence
antenatal growth may give important insight into the antecedents of early-onset asthma with implications for interventions.
1.Introduction
Asarule,mammalseitherhaveashortgestationandareborn
in an immature condition or have a long gestation but are
mature at term and can run or swim shortly after birth. One
exception to this rule is Homo sapiens who has a relatively
longgestationbutisstillimmatureatterm.Thereistherefore
a relatively large window of opportunity for both antenatal
and early post natal exposures to positively or negatively
aﬀect human development. The respiratory system provides
one example of human development spanning across ante-
natal and post natal periods since the airways are established
before the pregnancy reaches midpoint but alveoli start to
appear during the third trimester through to at least three
years of age [1]. Not unsurprisingly therefore, antenatal and
post natal exposures have been implicated in the causation of
respiratory disease.
Describing the impact of antenatal and post natal
exposures on development of the respiratory system is rel-
atively easy after birth and methods include symptom-based
questionnaires and physiological measurements. In contrast,
determining the eﬀect of antenatal exposures on the indi-
vidual’s respiratory wellbeing in utero is considerably more
challenging. To date, birth weight has been commonly used
as an index of fetal wellbeing and the assumption is that
adverse exposures on the respiratory system are manifest as
reduced growth. However, birth weight is the end point of
ninemonth’sgrowthand,asFigure 1demonstrates,insultsat
diﬀerent gestations might result in “catch-up growth” associ-
ated with high birth weight (outcome 1, Figure 1), normal
birth weight (outcome 2, Figure 1), or low birth weight
(outcome 3, Figure 1). For humans, the timing of a fetal
insult and ensuing catch-upgrowth is not yet fullydescribed,
butthesuggestedgrowthtrajectoriesdepictedinFigure 1can
be inferred from animal studies [2] and also observational
s t u d i e si nh u m a n s[ 3, 4]. Growth acceleration may also (the-
oretically) be a primary phenomenon, that is, not a response
to fetal growth failure. What is required is insight into fetal
wellbeing during antenatal life and how this is relevant to
post natal outcomes. Recently, longitudinal cohorts have
been established which are able to link fetal ultrasound mea-
surements made during pregnancy to post natal outcomes
[4–9]. These studies are able to explore the fetal origins
hypothesis, also termed developmental programming [10–
12], which proposes that “fetal undernutrition in middle
to late gestation, leads to disproportionate fetal growth,2 Clinical and Developmental Immunology
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Figure 1: Schematic diagram demonstrating how growth decel-
eration at diﬀerent gestations with resulting “catch-up growth”
may result in low, normal, or high birth weight. Insult 1 in early
pregnancy results in initial growth deceleration followed by growth
acceleration during mid and late pregnancy and post natal life and
is associated with increased birth weight (Outcome 1). Insult 2
occurs during mid pregnancy and results in growth deceleration
followedbygrowthaccelerationduringlaterpregnancyandinfancy,
associated with normal birth weight (Outcome 2). Insult 3 occurs
during late pregnancy leading to with low birth weight and
ensuing “catch-up growth” during infancy (Outcome 3). Outcome
4 illustrates normal growth throughout pregnancy and infancy.
programs later (coronary heart) disease” [10]. The present
review considers the relationship between fetal growth and
childhood asthma, the latter being an example of a chronic
condition where exposures in fetal life are thought to be
important to aetiology. The review has three aims.
(i) To summarise recent evidence linking birth anthro-
pometry and growth during infancy to respiratory
outcomes.
(ii) To explore the potential and limitations for using
fetal ultrasound measurements as an index for fetal
wellbeing.
(iii) Todescribetherecentliteraturelinkingfetalsize,fetal
growth trajectories,and respiratory outcomesin later
life.
2.BirthAnthropometry and
Respiratory Outcomes
There is a considerable literature relating birth size to asthma
symptoms in later life but no systematic review. There
is a systematic review summarising the literature relating
gestationtoasthma[13]wheretheconsensusisthatashorter
gestation at delivery is associated with increased risk for the
later development of asthma. For the purpose of the present
article, key words “Asthma” and “Birth weight” were used in
an Ovid search engine (to yield 129 abstracts) and relevant
papers published since 2000 were reviewed. Publications
known to the author but not identiﬁed by the search were
added (see Table 1). A formal systematic review on this topic
is required.
A number of themes emerge from this semistructured
literature review. First, there is no consensus on the relation-
ship between birth weight and asthma; nine studies ﬁnd an
inverse relationship [14–22], ten ﬁnd no relationship [23–
32], and three ﬁnd a positive relationship [33–35]. There
may be an issue of power since inverse relationships are seen
in large and very large study populations (median of 8071
individuals) whereas studies reporting no eﬀect tend to be of
medium size (median number of participants 3628). Second,
there is more consistent evidence of increased asthma among
those of low birth weight (i.e., less than 2.5kg) where there
is approximately a doubling in risk for asthma; it is not
clearwhetherthisisindependentofprematurity.Third,there
is limited evidence of increased asthma among very heavy
infants (i.e., >4.5kg) [33, 34]. Finally, other indices of size at
birth, for example, ponderal index [30, 35] (weight/length3),
may be more closely related to asthma compared to birth
weight.
Given the diﬀerent growth trajectories which may con-
verge to a given birth weight (Figure 1) it is perhaps not
surprising that the relationship between birth weight and
asthma is not straight-forward. Using birth weight as a “snap
shot” of fetal wellbeing has its limitations and in recognition
of this, post natal growth trajectory has been related to
asthma.
3.Post NatalWeight Gain,Asthma,
andLungFunction
Post natal growth trajectory may be a more accurate
reﬂection of antenatal growth compared to birth weight;
a movie picture rather than a photograph telling a story.
For example, an infant born on the 9th centile for birth
weight who demonstrates accelerated post natal growth and
reachesthe50thcentilebythreemonthsmightbeassumedto
have had growth suppression in utero. In contrast, a similar-
sized infant born on the 9th centile whose post natal growth
follows the 9th centile is simply marginally smaller than
average and most likely grew along the 9th centile in utero.
Ideally antenatal and post natal growth trajectories would be
obtained to study the relationship between early growth and
asthma outcomes.
What is important when understanding the relevance
of the relationship between somatic and pulmonary growth
is that whilst the body may be able to “catch up,” the
airways are established by mid pregnancy and may not
be able to catch up, leaving the individual with small
airways relative to body size. Proof-of-concept for dysanapsis
(i.e., dissociation between somatic and pulmonary growth)
comes from a cohort study of 1232 individuals from Chile
study where increased gain in weight and length during
infancy were associated with a modest increase in asthma
symptoms at age 23–29 [36]. Studies where followup is
only reported into childhood also ﬁnd positive associations
between weight gain during infancy and asthma risk. A
cohort in Southampton reported that increased weight and
adiposity(butnotlength)duringinfancywasassociatedwith
increased risk for wheeze at of age three years [7]. Paul and
colleagues [37] used data collected as part of a randomisedClinical and Developmental Immunology 3
T
a
b
l
e
1
:
S
u
m
m
a
r
y
o
f
s
t
u
d
i
e
s
l
i
n
k
i
n
g
b
i
r
t
h
w
e
i
g
h
t
t
o
a
s
t
h
m
a
.
S
t
u
d
y
r
e
f
e
r
e
n
c
e
Y
e
a
r
o
f
b
i
r
t
h
C
o
u
n
t
r
y
A
s
t
h
m
a
O
u
t
c
o
m
e
A
g
e
a
t
f
o
l
l
o
w
u
p
N
u
m
b
e
r
i
n
c
o
h
o
r
t
P
o
s
i
t
i
v
e
o
r
n
e
g
a
t
i
v
e
M
a
g
n
i
t
u
d
e
o
f
e
ﬀ
e
c
t
∗
[
2
1
]
1
9
2
8
–
1
9
5
2
S
w
e
d
e
n
D
o
c
t
o
r
d
i
a
g
n
o
s
e
d
a
s
t
h
m
a
,
a
s
t
h
m
a
a
d
m
i
s
s
i
o
n
o
r
d
e
a
t
h
3
6
–
7
0
y
e
a
r
s
2
1
,
5
8
8
t
w
i
n
s
N
e
g
a
t
i
v
e
O
R
f
o
r
2
k
g
1
.
5
8
[
1
.
0
6
,
2
.
3
8
]
c
o
m
p
a
r
e
d
t
o
2
.
5
k
g
[
2
7
]
1
9
4
7
–
1
9
7
3
N
o
r
d
i
c
-
B
a
l
t
i
c
c
o
u
n
t
r
i
e
s
W
h
e
e
z
e
,
w
h
e
e
z
e
w
i
t
h
s
h
o
r
t
n
e
s
s
o
f
b
r
e
a
t
h
2
0
–
4
7
y
e
a
r
s
1
6
8
3
N
o
a
s
s
o
c
i
a
t
i
o
n
W
h
e
e
z
e
r
e
d
u
c
e
d
b
y
2
%
[
±
1
9
%
]
f
o
r
e
a
c
h
5
0
0
g
w
t
g
a
i
n
B
i
r
t
h
w
e
i
g
h
t
2
5
0
0
v
e
r
s
u
s
4
0
0
0
g
l
i
n
k
e
d
w
i
t
h
8
%
i
n
c
r
e
a
s
e
i
n
F
E
V
1
[
3
2
]
1
9
6
6
F
i
n
l
a
n
d
D
o
c
t
o
r
d
i
a
g
n
o
s
e
d
a
s
t
h
m
a
e
v
e
r
a
n
d
s
y
m
p
t
o
m
s
i
n
l
a
s
t
1
2
m
o
n
t
h
s
3
1
y
e
a
r
s
4
7
1
9
N
o
a
s
s
o
c
i
a
t
i
o
n
U
s
i
n
g
p
o
n
d
e
r
a
l
i
n
d
e
x
t
e
r
t
i
l
e
s
a
n
d
m
i
d
d
l
e
a
s
r
e
f
e
r
e
n
c
e
,
r
i
s
k
f
o
r
a
s
t
h
m
a
i
n
l
o
w
e
s
t
1
.
1
4
[
0
.
7
8
,
1
.
6
5
]
a
n
d
f
o
r
h
i
g
h
e
s
t
1
.
2
2
[
0
.
8
5
,
1
.
7
5
]
.
P
o
n
d
e
r
a
l
i
n
d
e
x
h
a
d
s
i
g
n
i
ﬁ
c
a
n
t
U
-
s
h
a
p
e
d
r
e
l
a
t
i
o
n
s
h
i
p
w
i
t
h
s
k
i
n
p
r
i
c
k
p
o
s
i
t
i
v
i
t
y
[
1
5
]
1
9
7
0
–
1
9
8
9
U
K
H
o
s
p
i
t
a
l
a
d
m
i
s
s
i
o
n
f
o
r
a
s
t
h
m
a
2
–
1
0
y
e
a
r
s
2
4
8
6
1
2
r
e
c
r
u
i
t
e
d
4
0
1
7
a
d
m
i
t
t
e
d
N
e
g
a
t
i
v
e
R
i
s
k
i
n
c
r
e
a
s
e
d
2
0
%
[
1
0
–
3
0
]
c
o
m
p
a
r
i
n
g
1
–
3
k
g
v
e
r
s
u
s
3
–
4
k
g
[
3
0
]
1
9
7
5
–
1
9
7
9
F
i
n
l
a
n
d
L
i
f
e
t
i
m
e
p
r
e
v
a
l
e
n
c
e
d
o
c
t
o
r
-
d
i
a
g
n
o
s
e
d
a
s
t
h
m
a
1
6
y
e
a
r
s
3
0
6
5
t
w
i
n
p
a
i
r
s
N
o
a
s
s
o
c
i
a
t
i
o
n
O
R
0
.
6
1
[
0
.
3
0
,
1
.
2
4
]
f
o
r
2
.
5
–
3
k
g
v
e
r
s
u
s
<
2
k
g
.
O
R
h
i
g
h
e
s
t
v
e
r
s
u
s
l
o
w
e
s
t
q
u
a
r
t
i
l
e
f
o
r
p
o
n
d
e
r
a
l
i
n
d
e
x
(
w
t
/
l
e
n
g
t
h
3
)
1
.
8
2
[
1
.
1
8
,
2
.
7
9
]
[
2
6
]
1
9
7
5
–
1
9
8
8
U
K
A
s
t
h
m
a
d
i
a
g
n
o
s
i
s
1
3
–
1
4
y
e
a
r
s
1
0
,
8
0
9
N
o
a
s
s
o
c
i
a
t
i
o
n
f
o
r
b
i
r
t
h
w
e
i
g
h
t
H
i
g
h
e
s
t
v
e
r
s
u
s
l
o
w
e
s
t
q
u
i
n
t
i
l
e
h
e
a
d
c
i
r
c
u
m
f
e
r
e
n
c
e
i
n
c
r
e
a
s
e
d
h
a
y
f
e
v
e
r
(
1
.
2
3
[
1
.
0
3
,
1
.
4
7
]
)
.
H
i
g
h
e
s
t
q
u
i
n
t
i
l
e
b
i
r
t
h
w
t
i
n
c
r
e
a
s
e
d
h
a
y
f
e
v
e
r
(
1
.
1
7
[
0
.
9
9
,
1
.
3
9
]
)
.
H
i
g
h
e
s
t
v
e
r
s
u
s
l
o
w
e
s
t
b
i
r
t
h
w
e
i
g
h
t
0
.
9
2
[
0
.
6
2
,
1
.
3
5
]
[
2
5
]
1
9
7
7
–
1
9
8
0
A
u
s
t
r
a
l
i
a
A
s
t
h
m
a
M
e
a
n
1
4
y
e
a
r
s
1
8
0
p
r
e
t
e
r
m
a
n
d
4
2
t
e
r
m
d
e
l
i
v
e
r
i
e
s
N
o
a
s
s
o
c
i
a
t
i
o
n
A
s
t
h
m
a
p
r
e
v
a
l
e
n
c
e
2
1
%
i
n
c
o
n
t
r
o
l
s
,
2
1
%
i
n
1
–
1
.
5
k
g
b
i
r
t
h
w
t
a
n
d
1
5
%
i
n
0
.
5
–
1
k
g
b
i
r
t
h
w
t
[
3
5
]
1
9
8
4
–
1
9
8
7
D
e
n
m
a
r
k
H
o
s
p
i
t
a
l
a
d
m
i
s
s
i
o
n
f
o
r
“
d
e
ﬁ
n
i
t
e
”
o
r
“
a
n
y
”
a
s
t
h
m
a
1
2
y
e
a
r
s
1
0
4
4
0
P
o
s
i
t
i
v
e
D
e
ﬁ
n
i
t
e
a
s
t
h
m
a
i
n
c
r
e
a
s
e
d
1
.
6
2
[
1
.
0
2
,
2
.
5
9
]
f
o
r
a
b
o
v
e
c
o
m
p
a
r
e
d
w
i
t
h
b
e
l
o
w
a
v
e
r
a
g
e
b
i
r
t
h
w
e
i
g
h
t
.
M
o
r
e
c
o
n
v
i
n
c
i
n
g
r
e
l
a
t
i
o
n
s
h
i
p
b
e
t
w
e
e
n
i
n
c
r
e
a
s
i
n
g
p
o
n
d
e
r
a
l
i
n
d
e
x
a
n
d
a
n
y
a
n
d
d
e
ﬁ
n
i
t
e
a
s
t
h
m
a
a
d
m
i
s
s
i
o
n
[
3
4
]
1
9
8
5
–
1
9
8
8
C
a
n
a
d
a
E
m
e
r
g
e
n
c
y
v
i
s
i
t
s
f
o
r
a
s
t
h
m
a
1
0
y
e
a
r
s
8
3
,
5
9
5
c
h
i
l
d
r
e
n
P
o
s
i
t
i
v
e
a
b
o
v
e
4
.
5
k
g
A
b
o
v
e
4
.
5
k
g
i
n
c
r
e
a
s
e
d
r
i
s
k
(
1
.
1
6
[
1
.
0
4
,
1
.
2
9
]
)
c
o
m
p
a
r
e
d
t
o
n
o
r
m
a
l
w
e
i
g
h
t
.
B
e
y
o
n
d
4
.
5
k
g
1
0
%
i
n
c
r
e
a
s
e
r
i
s
k
[
2
,
1
9
]
.4 Clinical and Developmental Immunology
T
a
b
l
e
1
:
C
o
n
t
i
n
u
e
d
.
S
t
u
d
y
r
e
f
e
r
e
n
c
e
Y
e
a
r
o
f
b
i
r
t
h
C
o
u
n
t
r
y
A
s
t
h
m
a
O
u
t
c
o
m
e
A
g
e
a
t
f
o
l
l
o
w
u
p
N
u
m
b
e
r
i
n
c
o
h
o
r
t
P
o
s
i
t
i
v
e
o
r
n
e
g
a
t
i
v
e
M
a
g
n
i
t
u
d
e
o
f
e
ﬀ
e
c
t
∗
[
3
3
]
1
9
8
6
F
i
n
l
a
n
d
D
o
c
t
o
r
d
i
a
g
n
o
s
e
d
a
s
t
h
m
a
1
6
9
4
7
9
P
o
s
i
t
i
v
e
a
t
v
e
r
y
h
i
g
h
e
s
t
w
e
i
g
h
t
H
i
g
h
e
s
t
b
i
r
t
h
w
t
(
>
4
.
5
1
k
g
)
h
a
d
g
r
e
a
t
e
s
t
a
t
o
p
i
c
a
s
t
h
m
a
r
i
s
k
2
.
4
[
1
.
3
3
,
4
.
3
2
]
c
o
m
p
a
r
e
d
t
o
2
.
5
–
3
.
3
4
k
g
[
1
6
]
1
9
8
7
F
i
n
l
a
n
d
H
o
s
p
i
t
a
l
i
s
a
t
i
o
n
o
r
f
r
e
e
e
n
t
i
t
l
e
m
e
n
t
t
o
a
s
t
h
m
a
m
e
d
i
c
a
t
i
o
n
7
y
e
a
r
s
6
0
2
5
4
N
e
g
a
t
i
v
e
B
i
r
t
h
w
t
<
2
.
5
k
g
O
R
f
o
r
a
s
t
h
m
a
1
.
8
3
[
1
.
5
0
,
2
.
2
4
]
i
n
d
e
p
e
n
d
e
n
t
o
f
m
a
t
e
r
n
a
l
s
m
o
k
i
n
g
[
1
4
]
1
9
8
8
U
S
A
P
h
y
s
i
c
i
a
n
d
i
a
g
n
o
s
e
d
a
s
t
h
m
a
b
y
a
g
e
3
y
e
a
r
s
0
–
4
y
e
a
r
s
8
0
7
1
N
e
g
a
t
i
v
e
<
1
.
5
k
g
O
R
2
.
9
[
2
.
3
,
3
.
6
]
,
1
.
5
–
2
.
5
k
g
O
R
1
.
4
[
1
.
1
,
1
.
8
]
c
o
m
p
a
r
e
d
t
o
≥
2
.
5
k
g
[
2
3
]
1
9
8
8
–
1
9
9
0
N
e
t
h
e
r
l
a
n
d
s
P
a
r
e
n
t
r
e
p
o
r
t
e
d
a
s
t
h
m
a
M
e
a
n
6
y
e
a
r
s
1
9
6
1
N
o
a
s
s
o
c
i
a
t
i
o
n
f
o
r
b
i
r
t
h
w
e
i
g
h
t
R
e
l
a
t
i
o
n
s
h
i
p
b
e
t
w
e
e
n
a
s
t
h
m
a
a
n
d
g
e
s
t
a
t
i
o
n
a
l
a
g
e
(
r
i
s
k
f
o
r
>
3
6
w
e
e
k
s
2
.
0
[
1
.
0
,
4
.
0
]
c
o
m
p
a
r
e
d
t
o
4
0
w
e
e
k
s
)
a
n
d
a
s
t
h
m
a
a
n
d
h
e
a
d
c
i
r
c
u
m
f
e
r
e
n
c
e
:
b
i
r
t
h
w
e
i
g
h
t
r
a
t
i
o
(
r
i
s
k
f
o
r
a
b
o
v
e
m
e
d
i
a
n
1
.
8
[
1
.
1
,
3
.
2
]
c
o
m
p
a
r
e
d
w
i
t
h
b
e
l
o
w
m
e
d
i
a
n
)
.
[
2
0
]
1
9
9
2
–
1
9
9
8
S
w
e
d
e
n
E
v
e
r
h
a
d
a
s
t
h
m
a
9
–
1
2
y
e
a
r
s
4
4
6
t
w
i
n
s
N
e
g
a
t
i
v
e
O
R
1
.
5
7
[
1
.
3
8
,
1
.
7
9
]
f
o
r
e
a
c
h
k
g
d
e
c
r
e
a
s
e
[
2
8
]
1
9
9
4
–
1
9
9
6
S
w
e
d
e
n
W
h
e
e
z
e
4
y
e
a
r
s
2
8
6
9
N
o
a
s
s
o
c
i
a
t
i
o
n
f
o
r
b
i
r
t
h
w
e
i
g
h
t
B
i
r
t
h
l
e
n
g
t
h
≥
9
0
t
h
c
e
n
t
i
l
e
O
R
a
n
y
w
h
e
e
z
e
0
.
4
[
0
.
2
1
,
0
.
7
7
]
[
2
9
]
1
9
9
4
–
1
9
9
6
U
S
A
P
h
y
s
i
c
i
a
n
d
i
a
g
n
o
s
e
d
p
l
u
s
w
h
e
e
z
e
i
n
t
h
e
l
a
s
t
y
e
a
r
6
y
e
a
r
s
4
5
4
a
t
r
i
s
k
f
o
r
a
s
t
h
m
a
N
o
a
s
s
o
c
i
a
t
i
o
n
B
i
r
t
h
w
e
i
g
h
t
<
2
.
5
k
g
O
R
a
s
t
h
m
a
1
.
0
5
[
0
.
4
0
,
2
.
7
3
]
.
G
e
s
t
a
t
i
o
n
<
3
8
.
5
w
e
e
k
s
a
s
s
o
c
w
i
t
h
i
n
c
r
e
a
s
e
d
a
s
t
h
m
a
(
O
R
4
.
7
[
2
.
1
,
1
0
.
5
]
)
[
1
7
]
1
9
9
4
–
2
0
0
0
D
e
n
m
a
r
k
H
i
s
t
o
r
y
o
f
a
s
t
h
m
a
3
-
9
y
e
a
r
s
8
2
8
0
t
w
i
n
p
a
i
r
s
N
e
g
a
t
i
v
e
A
s
t
h
m
a
a
s
s
o
c
w
i
t
h
1
2
2
g
l
o
w
e
r
b
i
r
t
h
w
e
i
g
h
t
[
8
5
,
1
6
0
]
.
R
i
s
k
i
n
c
r
e
a
s
e
d
b
y
4
%
p
e
r
1
0
0
g
w
t
r
e
d
u
c
t
i
o
n
[
3
1
]
1
9
9
5
–
2
0
0
1
C
a
n
a
d
a
H
o
s
p
i
t
a
l
a
d
m
i
s
s
i
o
n
o
r
>
1
p
h
y
s
i
c
i
a
n
v
i
s
i
t
s
w
i
t
h
a
s
t
h
m
a
o
v
e
r
2
y
e
a
r
s
6
6
8
7
,
1
9
4
N
o
a
s
s
o
c
i
a
t
i
o
n
E
x
t
r
e
m
e
l
y
h
e
a
v
y
(
>
6
.
5
k
g
)
O
R
1
.
2
1
[
0
.
6
7
,
2
.
1
9
]
[
2
2
]
A
p
p
r
o
x
1
9
9
5
–
2
0
0
1
U
S
A
?
1
–
5
y
e
a
r
s
2
4
1
0
N
e
g
a
t
i
v
e
L
i
n
e
a
r
2
0
%
i
n
c
r
e
a
s
e
r
i
s
k
[
2
,
3
5
]
f
o
r
e
a
c
h
k
g
r
e
d
u
c
t
i
o
n
i
n
b
i
r
t
h
w
e
i
g
h
t
.
B
r
e
a
s
t
f
e
e
d
i
n
g
a
p
p
a
r
e
n
t
l
y
p
r
o
t
e
c
t
i
v
e
o
f
i
n
ﬂ
u
e
n
c
e
o
f
l
o
w
b
i
r
t
h
w
e
i
g
h
t
[
2
4
]
1
9
9
6
-
1
9
9
7
N
e
t
h
e
r
l
a
n
d
s
D
o
c
t
o
r
d
i
a
g
n
o
s
e
d
M
e
a
n
7
y
e
a
r
s
3
6
2
8
N
o
a
s
s
o
c
i
a
t
i
o
n
R
e
l
a
t
i
o
n
s
h
i
p
b
e
t
w
e
e
n
b
i
r
t
h
w
e
i
g
h
t
a
n
d
w
h
e
e
z
e
(
r
i
s
k
i
n
c
r
e
a
s
e
d
b
y
1
7
%
[
1
,
3
5
]
f
o
r
e
a
c
h
k
g
r
e
d
u
c
t
i
o
n
i
n
b
i
r
t
h
w
e
i
g
h
t
[
1
8
]
1
9
9
6
–
2
0
0
4
F
i
n
l
a
n
d
A
s
t
h
m
a
d
i
a
g
n
o
s
i
s
a
n
d
p
r
e
s
c
r
i
b
e
d
i
n
h
a
l
e
d
s
t
e
r
o
i
d
s
o
r
m
o
n
t
e
l
u
k
a
s
t
T
h
r
e
e
y
e
a
r
s
2
0
,
6
2
3
c
a
s
e
-
c
o
n
t
r
o
l
p
a
i
r
s
N
e
g
a
t
i
v
e
B
i
r
t
h
w
e
i
g
h
t
<
2
.
5
k
g
O
R
1
.
4
0
[
1
.
2
0
,
1
.
6
0
]
[
1
9
]
1
9
9
8
–
2
0
0
0
U
S
A
A
s
t
h
m
a
d
i
a
g
n
o
s
i
s
3
1
8
0
3
N
e
g
a
t
i
v
e
B
i
r
t
h
w
e
i
g
h
t
<
2
.
5
k
g
O
R
2
.
3
6
[
C
I
n
o
t
g
i
v
e
n
]
∗
O
R
=
o
d
d
s
r
a
t
i
o
f
o
r
a
s
t
h
m
a
.
N
u
m
b
e
r
s
i
n
s
q
u
a
r
e
b
r
a
c
k
e
t
s
c
o
r
r
e
s
p
o
n
d
t
o
9
5
%
c
o
n
ﬁ
d
e
n
c
e
i
n
t
e
r
v
a
l
s
.Clinical and Developmental Immunology 5
controlledtrialofinhaledcorticosteroidsinwheezy2-3-year-
old children and related change in weight between birth
and enrolment to asthma outcomes including burden of
symptoms, quality of life, functional capacity, exacerbations
of asthma and medication side eﬀects. Compared with
reduced growth, accelerated growth was associated with a
50% increase in exacerbations requiring prednisolone treat-
ment (0.6/year/child versus 0.9/year/child) and more than a
100%increaseinunscheduledphysicianvisits(0.5/year/child
versus 1.1/year/child). Although there is a relative paucity
of data linking growth in infancy to asthma diagnosis and
symptoms, this limited literature is entirely consistent. The
literature linking weight gain and pulmonary function is less
consistent.
In infancy, rapid early weight gain is associated with
reduced FEV0.4 at one month [38] and reduced mid expira-
tory ﬂow at the end of infancy [39] but a trend for increased
mid expiratory ﬂow at age 11 years [39]. In a large cohort
study in the Avon region of UK, infants with birth weight <
10th centile who demonstrate catch-up growth had evidence
ofbetterlungfunctionas7-8yearoldscomparedtothoseofa
similar weight who do not catch up but still lower than peers
of average birth weight [40]. The improved lung function in
the “catch-up” group was not signiﬁcantly better than the
persistently small infants despite this being a very large study
populationandtheresultscouldbeinterpretedassupporting
theconceptofdysanapsisorpossiblyindicatingthatcatchup
in somatic growth may be associated with very small degree
of catch up in pulmonary growth [40].
Cohorts with followup into adulthood have demon-
stratedincreasedweightgainduringinfancybeingassociated
with increased lung function in adults, that is, a reversal of
the relationship seen between weight gain and lung function
in infancy. For men aged 31 years, this was equivalent to
a mean increase of 51mLs FVC for each kg gained and
for women, mean increases of 19mLs FEV1 and 30mLs
FVC [41]. In a second study increased growth during ﬁrst
three years was associated with increased functional residual
capacity and gas transfer at 32 years of age [42] but not with
altered FEV1. The transformation of the association between
post natal growth and lung function from negative in infants
to positive in adults is diﬃcult to understand but might be
ac o h o r te ﬀect, that is, the nature of the relationship has
changed over time.
Findings from these epidemiological studies could be
interpreted as follows.
(i) A more rapid increase in size during infancy is
associated with increased risk for asthma.
(ii) A more rapid increase in size during infancy is
associatedwithreducedlungfunctionduringinfancy
but marginally increased lung function during adult-
hood.
4. Application of Fetal Measurements to
Epidemiological Studies
Ultrasonography provides a unique view of the developing
fetus, and in many countries ultrasound examinations are
Fetal head
Fetal spine
CRL
Figure 2: Ultrasound image of a 12-week fetus. The broken yellow
line is the crown rump length (CRL) measurement.
routinelycarriedouttodatepregnanciesintheﬁrsttrimester
(usually at approximately week 10) and detect congenital
abnormalitiesduringandafterthesecondtrimester(approx-
imately week 20). The interpretation of fetal measurements
in the context of post natal outcomes is not necessarily
straightforward and there are a number of methodological
considerations each of which apparently weaken any rela-
tionship between fetal size and later health outcomes.
First, diﬀerent measurements are made at diﬀerent
gestations, so which measurement is “best”? Crown rump
length (Figure 2) is measured in the ﬁrst trimester to date
a pregnancy and is known to be a very accurate predictor
of gestation in the ﬁrst trimester [43]b u tb e c o m e sm o r e
variable beyond 14 weeks [43] and other measurements
are required. Second trimester fetal measurements include
biparietal diameter [44], femur length [45], and abdom-
inal girth [46] and are not routinely measured in the
ﬁrst trimester since the fetus is so small. Even modern
ultrasound may lack precision for head, abdominal, and
limb measurements in a ten-week fetus which on average
measures 45mm from crown to rump. At birth, weight,
crown-heel length, and occipitofrontal circumference can
be measured but these are not directly comparable to ﬁrst
and second trimester measurements. Unfortunately, there
is no single “gold standard” fetal measurement which can
be made throughout pregnancy. Second, even in health,
fetal growth is not linear over time [47] and an apparent
acceleration or deceleration may be normal. Third, in the
context of fetal “stress” there is sparing of head growth
at the expense of the body which leads to asymmetrical
growth retardation; in the context of fetal “stress,” the fetal
head measurement may be within the normal range but
the abdominal girth will be reduced. Fourth, as with all
measurementsthereisanelementofinterobservervariability
and ﬁrst trimester fetal measurements, this is estimated to
be approximately 10% [48]. In epidemiological studies, the
impact of factors such as nonlinear growth and intrasubject
variation in measurements can be minimised by inclusion of
large numbers of participants.
Finally, and perhaps most importantly, anthropometric
measurements are not necessarily related to the function6 Clinical and Developmental Immunology
Table 2: Summary of asthma and allergy outcomes in the context of changing growth trajectory during early pregnancy.
First-second trimester
Increased rate of growth Reduced rate of growth
Asthma symptoms Atopy Lung function Asthma symptoms Atopy Lung
function
Southampton 3 years Increased skin
prick positivity
Increased
nonatopic wheeze
Aberdeen 5 years Increased asthma Reduced FEV1,F V C ,
FEF25–75
Reduced
FEV1
Aberdeen 10 years Increased asthma Increased hayfever Reduced FEF25–75 Increased asthma Reduced eczema Reduced
FVC
Table 3: Summary of asthma and allergy outcomes in the context of changing growth trajectory during late pregnancy.
Second-third
trimester
Increased rate of growth Reduced rate of growth
Symptoms Atopy Lung function Symptoms Atopy Lung
function
Southampton Increased atopic
wheeze
Increased skin
prick positivity
Aberdeen 5 years Increased asthma∗
Aberdeen 10 years Increased asthma Reduced FEV1 and
FVC
∗Data not published but can be conﬁrmed by the author.
of individual organ systems, for example, cardiovascular
system. However, spirometry is positively correlated with
anthropometric measurements in children including sitting
height [49] (i.e., crown rump length) and limb length [50]
(i.e., femur length) and therefore it is biologically plausible
that fetal measurements are a valid index of respiratory
function.
5. Fetal GrowthTrajectory and
Asthma and Allergy Outcomes
At the time of writing, fetal growth has been related to
childhood asthma outcomes in three reports from two
cohorts [7, 9, 51]. Methodological diﬀerences between the
two cohorts make direct comparison diﬃcult but there are
some patterns which emerge (Tables 2 and 3).
In a cohort recruited in Southampton [7], prospective
fetal measurements were made at 10, 19, and 34 weeks
gestation. The same fetal measurements were made on each
assessment, that is abdominal and head circumference, and
this allows relative change in the same measurement to be
studied. The Southampton group have focussed on relative
change in growth and have not yet reported associations
between absolute fetal size and childhood asthma outcomes.
In their paper, Pike et al. [7] report an association between
reduced head circumference growth between weeks 10 and
19 and reduced growth in abdominal girth between weeks
19 and 34 and increased wheeze at age three. Contrasting
associations between fetal growth trajectory and atopy at
age three years were seen; increasing abdominal growth
between 10 and 19 weeks but reduced growth of the same
parameter between weeks 19 and 34 were linked to increased
risk for atopy. Although based on a very young group of
individuals, these ﬁndings provide proof-of-concept that
factors which inﬂuence antenatal growth may be important
to asthma and atopy. Additionally these ﬁndings may explain
the inconsistent association between asthma and atopy, for
example, increased growth in early pregnancy may increase
atopy but reduce asthma risk whereas faltering growth in
later pregnancy may be associated with both.
A second cohort, recruited in Aberdeen [9, 51], was
primarily designed to relate dietary exposures to childhood
asthma outcomes and fetal measurements from routine ﬁrst
trimester “dating” and second trimester “fetal anomaly”
ultrasound examinations were retrieved retrospectively. This
meant that not all fetal measurements could be retrieved
and diﬀerent fetal measurements were made in the ﬁrst and
second trimester, whilst third trimester measurements were
those made at delivery, that is, birth weight, length, and head
circumference. Strengths of the Aberdeen cohort include
relatively extended followup at ages ﬁve and ten years,
inclusion of physiological measurements in childhood (e.g.,
spirometry), and relation of absolute fetal size to asthma
outcomes. The Aberdeen group have also looked at some
maternal factors which aﬀect fetal growth [8, 51].
At ﬁve years of age, the main message from the Aberdeen
cohort was that reduced fetal size in the ﬁrst trimester was
associated with increased risk for asthma symptoms and
obstructed lung function regardless of later fetal growth
[51]. Those who were initially short and then became larger
had worse asthma outcome compared to those who were
persistently large. To place fetal measurements into context,
the average fetus measured 46mm at ten weeks and asthma
riskatﬁveyearsfellbyanaverageof5%foreachmmincrease
in size.
As part of the evaluation of the Aberdeen cohort at age
ﬁve years, fetal size was related to maternal diet and smoking
during pregnancy. Reduced ﬁrst trimester fetal size wasClinical and Developmental Immunology 7
associated with reduced maternal plasma alpha tocopherol
(vitamin E) suggesting that maternal diet may be important
to early asthma causation [51]. The concept that vitamin
E may enhance fetal lung growth is supported by work in
animal models [52, 53] but it is also possible that increased
vitaminEismerelyanindexofagenerallyhealthiermaternal
diet during pregnancy and a single nutrient is not likely
to have a considerable impact on fetal growth in isolation.
Additional factors associated with fetal growth were male
gender which was associated with increased growth during
ﬁrst and second trimesters [51] and maternal smoking,
which was associated with reduced femur length [8]. There
are a number of mechanisms whereby maternal smoking
may aﬀect fetal and lung development. Carbon monoxide,
a by-product of tobacco smoking, induces fetal hypoxia [54]
which may directly induce fetal growth failure. Products of
tobaccosmokecanindirectlyaﬀectfetalgrowthviaanegative
inﬂuence on placental function [55]; for example, nicotine
causes vasoconstriction in placental vessels [55]. Maternal
smoking may also reduce fetal growth by suppression of
placental growth hormone and fetal insulin-like growth
factor endocrine function [56]. Finally, and not to the
exclusion of the previous mechanisms, maternal (and also
perhaps grandmaternal smoking) may induce epigenetic in
the developing fetus which could increase the unborn child’s
risk for asthma in later life [57].
At ten years of age, the main message from the Aberdeen
cohort remained that reduced ﬁrst trimester fetal size was
linked to a poorer asthma outcome. Asthma outcomes
were worst in those who were persistently small, best in
those who were persistently large, and intermediate for
those with changing growth trajectories. Additionally, the
investigators demonstrated that reduced ﬁrst trimester fetal
size was associated with asthma which was present at both
ages ﬁve and ten years but not transient or later onset
asthma symptoms. Birth weight and ﬁrst trimester fetal size
were independently associated with reduced lung function
at ten years suggesting that an element of remodelling
of the respiratory system may be taking place throughout
pregnancy. At ten years, but not at age ﬁve years, there was
evidence that increased early growth was associated with
hayfever and reduced early growth was apparently protective
for eczema; there was no association between changing
growth trajectory and skin prick positivity at ten years.
Putting the results of the two cohorts together is not
straightforward due to the diﬀerences in methodology,
analytical approach and age at follow up, however some
broad conclusions can be drawn. First, changes in fetal
growth trajectory size do appear to inﬂuence the risk for
childhood asthma symptoms; for both cohorts reduced early
growth was associated with increased asthma symptoms
(Table 2). In later pregnancy, the Aberdeen group report
increased asthma associated with increased growth in late
pregnancy but in contrast, the Southampton group observed
growth failure was associated with increased symptoms
(Table 3). Second, early growth acceleration was associated
with increased risk for atopy and atopic conditions in both
cohorts; interestingly this pattern is the opposite predicted
by the Barker hypothesis [10] but this was proposed for
cardiovascular outcomes and not atopy. Other cohorts
in Australia and Netherlands can shortly be expected to
report on asthma and associated outcomes in the context
of fetal growth and these will be welcome additions to
the present literature. What is clear is that factors which
inﬂuence fetal size and growth are important to childhood
asthma outcomes and antenatal interventions may prevent
childhood asthma, for example, by inﬂuencing maternal diet
or smoking.
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